FDA Looks to Social Media to Crack Down on Unapproved Drug Claims
Recently the FDA has issued warning letters to companies, stating that their products are considered unapproved new drugs. The FDA came to this decision based on the testimonials found on the companies’ Facebook and Twitter accounts. The statements found on these pages referred to claims that are not suitable to use for dietary supplements.
Most companies have been given fifteen days to correct their violations or face further regulatory action. View one of the FDA warning letters here. For questions regarding dietary supplement claims, Registrar Corp is available for discussion by phone at +1-757-224-0177 or 24/7 via online Live Help. To receive U.S. FDA regulatory updates, visit: http://www.registrarcorp.com/fda-updates